Key result
Oral diazepam premedication prior to cardiac catheterization or PCI did not alter the composite of access site complications and vasovagal events.
Why the study?
Does premedication with oral diazepam reduce access site complications, anxiety, and pain in patients undergoing cardiac catheterization or percutaneous coronary intervention?
RCT (n=760)
randomized
Does premedication with oral diazepam reduce access site complications, anxiety, and pain in patients undergoing cardiac catheterization or percutaneous coronary intervention?
Premedication with oral diazepam before cardiac catheterization or PCI reduces periprocedural pain without increasing access site complications.
Answers are grounded in this paper and cite their sources.
Oral diazepam appears safe for access complications; extends RCT evidence supporting its use to reduce periprocedural pain.
BACKGROUND: The aim of the study was to determine whether premedication with oral diazepam (5-10 mg) before coronary angiography or percutaneous coronary intervention was associated with an increase in access site related complications. We also aimed to determine the effect on patient's perception of anxiety and pain. METHODS: A total of 760 consecutive patients scheduled to undergo either cardiac catheterization or percutaneous coronary intervention were randomized to either premedication with diazepam 5-10 mg 30 to 60 minutes prior to procedures (n = 379) or no premedication (n = 381). Administration of intravenous midazolam during the procedures was permitted and was at the operator's discretion. The primary end point of the study was a composite of hematoma (>or=3 cm), pseudoaneurysm (requiring surgical repair), arterial bleeding (requiring further compression), and vasovagal events. Secondary end points included the patient's perception of pain and anxiety (n = 144). RESULTS: Hematomas (17% vs 15%, P = .41), pseudoaneurysm (0.3% vs 0%, P = .31), arterial bleeding (3.4% vs 4.2%, P = .58), vasovagals (4% vs 3%, P = .32), and the combined primary end point (25% vs 22%, P = .145) were similar in the premedication and no premedication groups. There was also no difference in the number of patients experiencing periprocedural anxiety (36% vs 37%, P = .862). However, those premedicated with diazepam were significantly less likely to report periprocedural pain (32% vs 53%, P = .0114). CONCLUSIONS: Treatment with oral diazepam prior to cardiac catheterization and percutaneous coronary intervention does not alter rates of access site complications or anxiety, but does reduce periprocedural pain.
No takes yet. Share an insight, caveat, or question.
Woodhead et al. (2007) conducted an RCT in Cardiac catheterization or percutaneous coronary intervention (n=760). Oral diazepam vs. No premedication was evaluated on Composite of hematoma (>=3 cm), pseudoaneurysm (requiring surgical repair), arterial bleeding (requiring further compression), and vasovagal events (p=.145). Oral diazepam premedication prior to cardiac catheterization or PCI did not alter the composite of access site complications and vasovagal events.
Synapse has enriched 10 related papers. Consider them for comparative context: